Glucosio E Potassio Cloruro I Galenica Senese

Glucosio E Potassio Cloruro I Galenica Senese is an injectable solution that combines potassium chloride and glucose monohydrate. It is supplied as a sterile intravenous preparation intended for fluid and electrolyte replacement. The product is manufactured in the European Union and is available by prescription. It delivers potassium ions to address hypokalemia while providing glucose for energy and to facilitate intracellular potassium shift in clinical settings.

Glucosio E Potassio Cloruro I Galenica Senese is indicated for conditions where potassium and fluid balance need rapid correction, particularly in hospitalized patients. It is commonly used after surgery, during acute illness, or when oral supplementation is not feasible, and may be administered as part of a broader electrolyte management plan. - Treatment of hypokalemia resulting from gastrointestinal losses or diuretic therapy. - Replacement of potassium in patients with renal tubular disorders. - Fluid and electrolyte repletion during postoperative care. - Support of intracellular potassium shift in cases of insulin‑induced hypokalemia. - Provision of an energy source during rapid intravenous fluid therapy.

Intravenous administration of potassium chloride and glucose may be associated with a range of adverse reactions. The frequency and severity vary according to patient factors and infusion rate. These events are generally dose‑dependent and may be mitigated by appropriate monitoring and infusion techniques. Common: - Mild vein irritation or phlebitis at the infusion site. - Transient nausea, vomiting, or abdominal discomfort. - Temporary increase in blood glucose levels. - Local pain or burning sensation during injection. Serious: - Hyperkalemia leading to cardiac arrhythmias. - Severe hyperglycemia requiring insulin therapy. - Allergic reaction such as rash, itching, or anaphylaxis. - Lactate accumulation in patients with severe liver dysfunction.

Because the solution contains potassium and glucose, careful assessment is required before use to avoid complications related to electrolyte imbalance, blood glucose changes, and infusion-related risks. - Verify serum potassium and glucose levels prior to administration. - Adjust infusion rate to prevent rapid potassium rise. - Avoid use in patients with untreated hyperkalemia or severe renal impairment. - Monitor cardiac rhythm continuously during infusion. - Use caution in patients with diabetes mellitus or insulin resistance. - Ensure proper aseptic technique to reduce infection risk.

Potassium chloride and glucose can interact with other medications or clinical conditions, influencing electrolyte balance or glycemic control. Awareness of these interactions helps guide safe co‑administration. Avoid: - Concurrent use of other potassium‑containing products without dose adjustment. - Co‑administration with rapid‑acting insulin infusions that may precipitate severe hypokalemia. Use with caution: - Loop or thiazide diuretics that increase potassium loss. - ACE inhibitors, ARBs, or potassium‑sparing diuretics that raise serum potassium. - Hyperglycemic agents or oral antidiabetic drugs that may exacerbate glucose elevations. - Beta‑adrenergic agonists that can shift potassium intracellularly.